Leptomycin B is an inhibitor of nuclear export: Inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA

Chemistry and Biology

Volumn 4, Issue 2, 1997, Pages 139-147

  Wolff, Barbara ^a   Sanglier, Jean Jacques ^b   Wang, Ying ^b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b Preclinical Research   (Switzerland)

Author keywords

HIV 1 Rev; leptomycin B; nuclear export

Indexed keywords

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; STREPTOMYCES;

EID: 0031079648     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(97)90257-X     Document Type: Article

References (52)

1. Popovic, M., Sarngadharan M.G., Read, E. & Gallo, R.C. (1984). Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224, 497-500.
2. Varmus, H. (1988). Regulation of HIV and HTLV gene expression. Genss Dev. 2, 1055-1062.
3. Cullen, B.R. & Greene, W.C. (1989). Regulatory pathways governing HIV-1 replication. Cell 58, 423-426.
4. Arya, S., Guo, C., Josaphs, S.F. & Wong-Staal, F. (1985). Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). Science 229, 69-73.
5. Terwilliger, E., Burghoff, R., Sia, R., Sodroski, J., Haseltine, W. & Rosen, C. (1988), The art gene product of human immunodeficiency virus is required for replication. J. Virol. 62, 655-658.
6. Böhnlein, E., Berger, J. & Hauber, J. (1991). Functional mapping of the human immunodeficiency virus type 1 Rev RNA binding domain: new insights into the domain structure of Rev and Rex. J. Virol. 65, 7051-7055.
7. Arrigo, S.J. & Chen, I.S.Y. (1991). Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs. Genes Dev. 5, 808-819.
8. Felber, B., Hadzopoulou-Cladaras, M., Cladaras, C., Copeland, T. & Pavlakis, G.N. (1989). Rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc. Natl Acad. Sci. USA 86, 1485-1499.
9. Hammarskjöld, M.-L, Heumer, J., Hammarskjöld, B., Sangwan, I., Albert, L & Rekosh, D. (1989). Regulation of human immunodeficiency virus env expression by the rev gene product. J. Virol. 63, 1959-1966.
10. Malim, M.H., Hauber, J., Le, S.-Y., Maizel, J.V. & Cullen, B.R. (1989). The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 338, 254-257.
11. Matsukura, M., et al., & Broder, S. (1989). Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate deoxyoligonucleotide against rev (art/trs) in chronically infected cells. Proc. Natl Acad. Sci. USA 86, 4244-4248.
12. Bevec, D., Dobrovnik, M., Hauber, J. & Böhnlein, E. (1992). Inhibition of human immunodeficiency virus type 1 replication in human T cells by retroviral-mediated gene transfer of a dominant-negative Rev trans-activator. Proc. Natl Acad. Sci. USA 89, 9870-9874.
13. Bevec D., et al., & Hauber, J. (1996). Inhibition of HIV-1 replication in lymphocytes by mutants of the Rev cofactor elF-5A. Science 271, 1858-1860.
14. Duan, L., Bagasra, O., Laughlin, M.A., Oakes, J.W. & Pomerantz, R.J. (1994). Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody. Proc. Natl Acad Sci. USA 91, 5075-5079.
15. Lee, T,C., Sullenger, B.A., Gallardo, H.F., Ungers, G.E. & Gilboa, E. (1992). Overexpression of RRE-derived sequences inhibits HIV-1 replication in CEM cells. New Biol. 4, 66-74.
16. Zapp, M.L., Stern, S. & Green, M.R. (1993). Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production. Cell 74, 969-978.
17. Ciccarelli, R.B., et al., & Hughes, J.V. (1994). Inhibition of the cellular Rev response and HIV-1 replication by 8-alkyl-2-(4-pyridyl)pyrido[2,3-d]pyrimidin-5(8H)-ones. Antiviral Chem. Chemother. 5, 169-175.
18. Wolff, B., Cohen, G., Hauber, J., Meshcheryakova, D. & Rabeck, C. (1995). Nucleocytoplasmic transport of the Rev protein of human immunodeficiency virus type 1 is dependent on the activation domain of the protein. Exp. Cell Res. 217, 31-41.
19. Meyer, B.E. & Malim, M.H. (1994). The HIV-1 Rev trans-activator shuttles between nucleus and cytoplasm. Genes Dev. 8, 1538-1548.
20. Szilvay, A.M., Brokstad, K.A., Kopperud, R., Haukenes, G. & Kailand, K.-H. (1995). Nuclear export of the human immunodeficiency virus type 1 nucleocytoplasmic shuttle protein Rev is mediated by its activation domain and is blocked by trans dominant negative mutants. J. Virol. 69, 3315-3323.
21. Fischer, U., Huber, J., Boelens, W.C., Mattaj, I.W. & Lührmann, R. (1995). The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell 82, 475-483.
22. Wen, W., Meinkoth, J.L., Tsien, R.Y. &Taylor, S.S. (1995). Identification of a signal for rapid export of proteins from the nucleus Cell 82, 463-473.
23. Baeuerle, P.A. & Baltimore, D. (1988). Activation of DNA binding activity in an apparently cytoplasmic precursor of the NFκB transcription factor. Cell 53, 211-217.
24. Arenzana-Seisdedos, F., et al., & Hay, R.T. (1995). Inducible nuclear expression of newly synthesized IκBα negatively regulates DNA-binding and transcriptional activities of NFκB. Mol. Cell Biol. 15, 2689-2696.
25. Zabel, U., Henkel, T., dos Santos Silva, M. & Baeuerle, P.A. (1993). Nuclear uptake control of NFκB by MAD-3, an IκB protein present in the nucleus. EMBO J. 12, 201-211.
26. Beg, A.A., et al., & Baldwin, A.S. (1992). lκB interacts with the nuclear localization sequences of the subunits of NFκB: a mechanism for cytoplasmic retention. Genes Dev. 6, 1899-1913.
27. Paschal, B.M. & Gerace, L. (1995). Identification of NTF2, a cytosolic factor for nuclear import that interacts with nuclear pore complex protein p62. J. Cell Biol. 129, 925-937.
28. Melchior, F., Paschal, B., Evans, J. & Gerace, L. (1993). Inhibition of nuclear protein import by nonhydrolyzable analogues of GTP and identification of the smali GTPase Ran/TC4 as an essential transport factor. J. Cell Biol. 123, 1649-1659.
29. Malim, M.H., Hauber, J., Fenrick, R. & Cullen, B.R. (1988). Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes. Nature 335, 181-183.
30. Hamamoto, T., Gunji, S., Tsuji, H. & Beppu, T. (1983). Leptomycins A and B, new antifungal antibiotics I. Taxonomy of the producing strain and their fermentation, purification and characterization. J. Antibiot. (Tokyo) 36, 639-645.
31. Hamamoto, T., Seto, H. & Beppu, T. (1983). Leptomycins A and B, new antifungal antibiotics II. Structure elucidation. J. Antibiot. (Tokyo) 36, 646-650.
32. Hamamoto, T., Uozumi, T. & Beppu, T. (1985). Leptomycins A and B, new antifungal antibiotics III. Mode of action of leptomycin B on schizosaccharomyces pombe. J. Antibiot. (Tokyo) 38, 1573-1580.
33. Komiyama, K., et al., & Umezawa, I. (1985). Structural study of a new antitumor antibiotic, kazusamycin. J. Antibiot. (Tokyo) 38, 220-223.
34. Komiyama, K., Okada, K., Hirokawa, Y., Masuda, K., Tomisaka, S. & Umezawa, I. (1985). Antitumor activity of a new antibiotic, kazusamycin. J. Antibiot. (Tokyo) 38, 224-220.
35. Yoshida, E., et al., & Umezawa, I. (1987). Antitumor effect of kazusamycin B on experimental tumors. J. Antibiot (Tokyo) 40, 1596-1604.
36. Roberts, B.J., Hamelehle, K.L., Sebolt, J.S. & Leopold, W.R. (1986). In vivo and in vitro anticancer activity of the structurally novel and highly potent antibiotic CI-940 and its hydroxy analog (PD 114,721). Cancer Chemother. Pharmacol. 16, 95-101.
37. Takamiya, K., Yoshida, E., Takahashi, T., Okura, A. & Okanishi, M. (1988). The effect of kazusamycin B on the cell cycle and morphology of cultured L1210 cells. J. Antibiot. (Tokyo) 41, 1854-1861.
38. Yoshida, M., Nishikawa, M., Nishi, K., Abe, K., Horinouchi, S. & Beppu, T. (1990). Effects of leptomycin B on the cell cycle of fibroblasts and fission yeast cells. Exp. Cell Res. 187, 150-156.
39. Nishi, K., et al., & Beppu, T. (1992). A leptomycin B resistance gene of Schizosaccharomyces pombe encodes a protein similar to the mammalian P glycoproteins. Mol. Microbiol. 6, 761-769.
40. Nishi, K., Yoshida, M., Fujiwara, D., Nishikawa, M., Horinouchi, S. & Beppu, T. (1994). Leptomycin B targets a regulatory cascade of crm1, a fission yeast nuclear protein, involved in control of higher order chromosome structure and gene expression. J. Biol. Chem. 269, 6320-6324.
41. Palmeri, D. & Malim, M.H. (1996). The human T-cell leukemia virus type 1 posttranscriptional trans-activator Rex contains a nuclear export signal. J. Virol. 70, 6442-6445.
42. 2-terminal, leucine-rich short amino acid sequence, which acts as a nuclear export signal. J. Biol. Chem. 271, 20024-20028.
43. Fritz, C.C. & Green, M.R. (1996). HIV Rev uses a conserved cellular protein export pathway for the nucleo-cytoplasmic transport of viral RNAs. Curr. Biol. 6, 848-854.
44. Fridell, R-A., et al., & Cullen, B.R. (1996). Amphibian transcription factor IIIA proteins contain a sequence element functionally equivalent to the nuclear export signal of human immunodeficiency virus type 1 Rev. Proc. Natl Acad. Sci. USA 93, 2936-2940.
45. Cullen, B.R. (1987). Use of eukaryotic expression technology in the functional analysis of cloned genes. In Methods Enzymol. (Berger, S.L. & Kimmel, A.R., eds.), pp. 684-703, Academic Press, New York, USA.
46. Greenberg, M.E. & Ziff, E.B. (1984). Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature 311, 433-438.
47. Hope, T.J., Huang, X., McDonald, D. & Parslow, T.G. (1990). Steroidreceptor fusion of the human immunodeficiency virus type 1 Rev transactivator: mapping cryptic functions of the arginine-rich motif. Proc. Natl Acad Sci. USA 87, 7787-7791.
48. Ruhl, M., et al., & Hauber, J. (1993). Eukaryotic initiation factor 5A is an cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activation. J. Cell Biol. 123, 1309-1320.
49. Rouet, P., Raguenez, G. & Salier, J.-P. (1992). Optimized assays for quantifying transient expressions of co-transfected β-galactosidase and CAT reporter genes. Biotechniques 13, 700-701.
50. Perno, C.-F., et al., & Broder, S. (1989). Replication of human immunodeficiency virus in monocytes. J. Exp. Med. 169, 933-951.
51. Pauwels, R., et al., & De Clerqc, E. (1988). Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J. Virol. Methods 20, 309-321.
52. Skehan, P., et al., & Boyd, M. R. (1990). New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl Cancer Inst. 82, 1407-1112.